Dr Reddy's Laboratories Has Launched Sevelamer Carbonate Tablets In The US Market

Dr Reddy's Laboratories has launched Sevelamer Carbonate tablets in the US market.

"This is the company's eighth overall and fourth limited-competition launch this fiscal year," Alok Sonig, Executive Vice President and Head of North America Generics business said.

For the last 12 months ending in July 2017, the drug had US sales of approximately USD 1.88 billion, according to IMS Health.

Sevelamer is used to lower high blood phosphorus levels in patients.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory